PTX — Prescient Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$56.78m
- AU$47.98m
- AU$0.14m
Australia Stock Exchange release from PRESCIENT THERAP : Appendix 4E and 2021 Annual Report
Australia Stock Exchange release from PRESCIENT THERAP : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from PRESCIENT THERAP : Global brain cancer expert joins PTX advisory board
Australia Stock Exchange release from PRESCIENT THERAP : Notification regarding unquoted securities - PTX
Australia Stock Exchange release from PRESCIENT THERAP : Application for quotation of securities - PTX
Australia Stock Exchange release from PRESCIENT THERAP : Notification regarding unquoted securities - PTX
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 08:37:43
Australia Stock Exchange release from PRESCIENT THERAP : PTX successful immunogenicity testing of OmniCAR
Australia Stock Exchange release from PRESCIENT THERAP : Application for quotation of securities - PTX
Australia Stock Exchange release from PRESCIENT THERAP : PTX Completes CAR-T Manufacturing Milestone for OmniCAR
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 09:02:42
Australia Stock Exchange release from PRESCIENT THERAP : Response to ASX Price Query
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 14:23:05
Australia Stock Exchange release from PRESCIENT THERAP : Capital Structure Update - Expiry of Unlisted Options
Australia Stock Exchange release from PRESCIENT THERAP : PTX signs CAR-T agreement with Peter MacCallum
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 10:32:22
Australia Stock Exchange release from PRESCIENT THERAP : March 2021 Quarterly Update and Appendix 4C
Australia Stock Exchange release from PRESCIENT THERAP : PRE_NR Ends: 12:05:16
Australia Stock Exchange release from PRESCIENT THERAP : PTX-200 AML Trial Progresses to Higher Dose